Phase I Study of CD19-ARTEMIS® T Cells (EB103) in Patients with Aggressive B-Cell Non-Hodgkin Lymphoma

20260 citationsJournal Article

Authors

Good health and well-being

Published in: Transplantation and Cellular Therapy

Volume 32, Issue 3, pp. S17-S17

Field-Weighted Citation Impact: 0.00